RAFUTROMBOPAG

UNII:	9WGT51BDDL
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₂₂N₄O₅
Preferred Substance Name:	RAFUTROMBOPAG
InChIKey:	BDGGFTDRPHKXFC-QYQHSDTDSA-N
GSRS Full Record:	9WGT51BDDL i

2600513-51-5
(Z)-5-(2-HYDROXY-3-(2-(3-METHYL-5-OXO-1-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-4(5H)-YLIDENE)HYDRAZINYL)PHENYL) FURAN-2-CARBOXYLIC ACID
2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]-
HETROMBOPAG
Hetrombopag [WHO-DD]
SHR-8735
SHR8735
rafutrombopag
rafutrombopag [INN]

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i
PubChem
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAFUTROMBOPAG

Synonyms and Mappings

Resources